Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Samulski

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Nature Biotechnology|May 10, 2000
Expanding the AAV packageR J Samulski
Ernst Schering Research Foundation Workshop|August 5, 2003
AAV vectors, the future workhorse of human gene therapyR J Samulski
Current Opinion in Genetics & Development|February 1, 1993
Adeno-associated virus: integration at a specific chromosomal locusR J Samulski
Molecular Biotechnology|February 1, 1995
AAV as a viral vector for human gene therapy. Generation of recombinant virusF Rolling, R J Samulski
Journal of Virology|January 1, 1988
Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAsR J Samulski, T Shenk
Journal of Virology|January 28, 1998
Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virionsC Summerford, R J Samulski
Nature Medicine|May 6, 1999
Viral receptors and vector purification: new approaches for generating clinical-grade reagentsC Summerford, R J Samulski
Human Gene Therapy|August 20, 1996
NIDDK Workshop on AAV Vectors: Gene Transfer into Quiescent CellsC McKeon, R J Samulski
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeatS M Young, R J Samulski
Virology|December 19, 2000
Building a better vector: the manipulation of AAV virionsJ E Rabinowitz, R J Samulski
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Nature Biotechnology|May 10, 2000
Expanding the AAV packageR J Samulski
Ernst Schering Research Foundation Workshop|August 5, 2003
AAV vectors, the future workhorse of human gene therapyR J Samulski
Current Opinion in Genetics & Development|February 1, 1993
Adeno-associated virus: integration at a specific chromosomal locusR J Samulski
Molecular Biotechnology|February 1, 1995
AAV as a viral vector for human gene therapy. Generation of recombinant virusF Rolling, R J Samulski
Journal of Virology|January 1, 1988
Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAsR J Samulski, T Shenk
Journal of Virology|January 28, 1998
Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virionsC Summerford, R J Samulski
Nature Medicine|May 6, 1999
Viral receptors and vector purification: new approaches for generating clinical-grade reagentsC Summerford, R J Samulski
Human Gene Therapy|August 20, 1996
NIDDK Workshop on AAV Vectors: Gene Transfer into Quiescent CellsC McKeon, R J Samulski
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeatS M Young, R J Samulski
Virology|December 19, 2000
Building a better vector: the manipulation of AAV virionsJ E Rabinowitz, R J Samulski
Pageof 11